Dr. Chandanreddy Devireddy, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
550 Peachtree Street, Emory Crawford Long Hospital-mot 6th Floor
Atlanta, GA 30308
- Medicare participating
At a glance
- Medical school
- University of Michigan Medical School (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 460
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: University of Michigan Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
GA license 050156
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Emory University Hospital Atlanta, GA
- Emory University Hospital Midtown Atlanta, GA
Medical groups
- The Emory Clinic Inc (3,568 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 460
- Services billed
- 1,002
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 85 | 81 |
| Replacement of aortic valve through the skin and femoral artery | 75 | 75 |
| Established patient office or other outpatient visit, 30-39 minutes | 49 | 44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 48 | 46 |
| New patient office or other outpatient visit, 60-74 minutes | 46 | 46 |
| Established patient office or other outpatient visit, 20-29 minutes | 44 | 41 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 36 | 21 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 24 | 20 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 18 | 17 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Atlanta, GA | 77 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Atlanta, GA | 71 |
| Atorvastatin Calcium Other prescribers in Atlanta, GA | 67 |
| Carvedilol Other prescribers in Atlanta, GA | 59 |
| Metoprolol Succinate Other prescribers in Atlanta, GA | 47 |
| Amlodipine Besylate Other prescribers in Atlanta, GA | 42 |
| Spironolactone Other prescribers in Atlanta, GA | 42 |
| Losartan Potassium Other prescribers in Atlanta, GA | 38 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Atlanta, GA | 33 |
| Furosemide Other prescribers in Atlanta, GA | 29 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 16 payments worth $14,699 in total to this clinician.
| Medtronic, Inc. | $14,699 |
|---|
| Consulting Fee | $12,713 |
|---|---|
| Travel and Lodging | $1,552 |
| Food and Beverage | $434 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Dec 15, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $6,188 |
| Medtronic, Inc. Feb 25, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $5,400 |
| Medtronic, Inc. Nov 7, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $705 |
| Medtronic, Inc. Nov 14, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $675 |
| Medtronic, Inc. Aug 12, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $450 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $284 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $226 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $202 |
| Medtronic, Inc. Dec 4, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $100 |
| Medtronic, Inc. Nov 8, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Minneapolis, MN · in-kind | $33.95 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 4 companies. The companies reported $212,849 in research payments for these studies, mostly to the institutions running them.
- SPYRAL AFFIRM
Medtronic, Inc. - Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100 - SPYRAL HTN-ON MED
Medtronic, Inc. - NCT02000115--Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Abbott Laboratories - GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W. L. Gore & Associates, Inc. · Recruiting · NCT03821129
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.